[Organ transplantation: epidemiological and immunological aspects; principles of treatment and surveillance; complications and prognosis; ethical and legal aspects].
Lebranchu
Yvon
Y
Service de néphrologie, immunologie clinique, CHU hôpital Bretonneau, 37044 Tours Cedex. lebranchu@med.univ-tours.fr
Sirinelli
Agnès
A
Wolf
Philippe
P
Mornex
Jean-François
JF
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology; D016027:Heart Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016031:Liver Transplantation; D016040:Lung Transplantation; D008213:Lymphocyte Activation; D016377:Organ Transplantation / Q000009:adverse effects / Q000941:ethics / Q000331:legislation & jurisprudence / Q000706:statistics & numerical data; D016035:Pancreas Transplantation; D011183:Postoperative Complications; D013601:T-Lymphocytes / Q000276:immunology; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors; D014019:Tissue Donors; D020858:Tissue and Organ Harvesting; D014181:Transplantation Immunology; D014850:Waiting Lists
D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D016559:Tacrolimus